Iontophoresis is a promising method which utilizes an electric field to enhance the delivery of charged compounds across skin.
Iontophoresis is a promising method which utilizes an electric field to enhance the delivery of charged compounds across skin. 1, 2) Since drug administration is readily controlled by adjustment of the applied voltage or current, iontophoresis may become a useful technique for drug therapy at home. Conventional iontophoretic systems use direct current which frequently causes skin irritation due to change in pH 3) or continuous electrical polarization of the skin. 4) Moreover, changes in pH alter the ionization of organic compounds which exist in a pH-dependent equilibrium between their ionized and nonionized states. 5) Since an optimal iontophoretic effect requires maximal ionization, 6, 7) effective drug transport must minimize pH changes in the drug-containing solution. In order to overcome these disadvantages, systems using a silver or silver-silver chloride electrode 8, 9) or pulsed direct current 10) have been investigated. However, there have been few reports demonstrating both safety and drug availability when iontophoretic systems were used in vivo.
Recently, a novel iontophoretic device was developed by TTI ellebeau Inc. to improve the capabilities of current systems ( Fig. 1 ). This novel system transfers an ionic drug from the drug solution into the skin through an ion-exchange membrane. The counter ions are transported from the drug solution to an electrode buffer compartment, and do not pass from the skin into the drug solution due to the presence of the ion-exchange membrane. In this way, the balance between cations and anions in the drug solution can be kept constant. It is assumed that changes in pH due to oxidation and reduction reactions at the anode and cathode do not affect the conditions of the drug-containing solution, because the drug solution chamber and the electrode chamber are separated by ion-exchange membrane. It is also assumed that insults to the skin are relatively minor compared with conventional devices since the influx of endogenous ions from the skin into the drug solution is prevented by the presence of the ion-exchange membranes.
Transdermal delivery of non-steroidal anti-inflammatory drugs (NSAIDs) by iontophoresis would be advantageous since it would avoid hepatic first-pass metabolism and considerable gastrointestinal disturbances. 11, 12) However, as presently configured, iontophoretic delivery of anionic compounds, such as NSAIDs, is relatively inefficient because the negative charge on the surface of the skin electrostatically repels anionic drugs. 13) Therefore, further improvements in iontophoresis systems are required for efficient transdermal delivery of anionic drugs. The purpose of this study was to examine transdermal delivery of the anionic pharmacologic agent diclofenac sodium, a widely used NSAID, by a novel iontophoretic system. Previously, in vitro iontophoresis of insulin was enhanced by pretreatment of skin with a chemical enhancer. 14) Thus, we optimized the conditions for pharmacologically effective transdermal delivery of diclofenac sodium in vivo and also investigated the enhancing effect of the combined use of three terpenes as chemical enhancers of iontophoretic drug delivery.
MATERIALS AND METHODS

Materials and Experimental Animals
Diclofenac sodium, l-carrageenan, and geraniol were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The devices for ion-exchange iontophoresis (TCT TM ) and cation-or anion-exchange membranes were manufactured by TTI ellebeau Inc. (Tokyo, Japan). CAPCELL PAK C18 ACR (S-3 mm 4.6ϫ150 mm) columns were obtained from Shiseido Co., Ltd. (Tokyo, Japan). Ten-week-old male Sprague-Dawley (SD) rats were purchased from CLEA Japan, Inc. (Tokyo, Japan).
Instruments for in Vivo Iontophoretic Delivery of Diclofenac Sodium The devices for ion-exchange iontophoresis (TCT TM ) were consisted of acryl chambers containing electrode buffer or drug solution. The electrode and drug chambers had fluid volumes of 1 ml each. The electrode and drug chambers on the cathodic side were partitioned by a cation-exchange membrane, while those on the anodic side were partitioned by an anion-exchange membrane. The anion-exchange membrane was inserted between the cathodic drug chamber and the skin, and the cation-exchange membrane was inserted between the anodic drug chamber and the skin (Fig. 1 ). All the ion-exchange membranes were stored in isotonic saline, and the donor side anion-exchange membranes were soaked overnight in 12.5 mM diclofenac sodium in 200 mM phosphate buffer (pH 7.4) before use. Since the pK a value of diclofenac is around 4.0, it is likely that the drug molecule is completely ionized under the experimental conditions. Therefore, on and after, ionized diclofenac sodium salt was simply represented as 'diclofenac Ϫ .' The 20 mM phosphate buffers (pH 7.4) contained 12.5 mM diclofenac Ϫ were used as drug solutions. The electrode buffer (pH 5.0) contained 420 mM disodium fumarate, 19 mM sodium L-ascorbyl-2-phosphate and 139 mM polyacrylic acid (MW 25000). Since fumarate is a biogenic component, it is non-toxicity to the skin. Moreover, its disodium salts have high solubility in water (at least 420 mM), hence, it provides high electric conductivity. Furthermore, pH changes due to oxidation-reduction reactions at the electrodes were suppressed by the redox properties of fumarate and L-ascorbyl-2-phosphate. Polyacrylic acid is a highly absorbent polymer and provides high electric and ionic conductivity. The available surface area was 3.133 cm 2 . A pair of carbon electrodes was used and connected to a power supply (TTI ellebeau Inc., model TCCR-3005).
In Vivo Delivery: Evaluation of Anti-inflammatory Effects Dorsal skin was excised from 10-week-old male SD rats from which hair had been removed by Epilat (Kanebo Cosmetics Inc., Tokyo, Japan). A catheter was implanted in the jugular veins of rats under anesthesia. Inflammation was induced by injection of 100 ml of 1% (w/v) carrageenan solution to one hind paw of the rats, then paw volume was measured using a plethysmometer (paw volume meter) (Natsume Seisakusho Co., Ltd., model KN-356, Tokyo, Japan) 0, 0.5, 1, 1.5 and 2.5 h after injection. The percentage of swelling of the hind paw was calculated as the ratio of increased volume to starting volume of the hind paw. Two hours following injection of carrageenan, the same volume of carrageenan solution was injected into the other hind paw. At that time, the iontophoretic device TCT TM was pasted to the dorsal skin and iontophoresis was started using the following conditions. Current density was 0.3 mA/cm 2 , the concentration of diclofenac Ϫ was 12.5 mM, and the duration of treatment was 1.5 h. In the case of terpene treatment, 2 h after first injection of carrageenan, 100 ml of geraniol (100% concentration) was directly swabbed on the dorsal skin just before the second injection of carrageenan to the other hind paw, and then iontophoresis was performed. Blood samples were collected 0, 0.5, 1, 1.5 and 2.5 h after the second injection via an implanted catheter in the jugular vein and paw volume was measured. This protocol is summarized in Fig. 2 . Blood samples were centrifuged for 10 min at 5000 rpm (4°C) and the separated plasma was extracted with methanol as described previously.
15) The quantification of diclofenac Ϫ in the extract was performed using high performance liquid chromatography (HPLC) as reported previously.
16)
Statistical Analysis Statistical analyses of the differences between treatments were conducted with paired or unpaired Student's t-tests. p-values Ͻ0.05 were considered significant.
RESULTS
In Vivo Transdermal Delivery of Diclofenac: Evaluation of the Anti-inflammatory Effect To assess the delivery of diclofenac Ϫ into the rat's blood circulation by in vivo transdermal iontophoresis, the plasma concentrations of diclofenac Ϫ after iontophoresis and its anti-inflammatory effects on carrageenan-induced edema in the hind paw were investigated. As shown in Fig. 3A , the plasma concentration of diclofenac Ϫ was increased up to 0.17 mg/ml during iontophoresis. Contrary, in the case without iontophoresis (passive diffusion) diclofenac Ϫ was not detected in the plasma at all of time points.
As shown in Fig. 4 , skin irritation associated with use of conventional devices was considerably reduced by using the TCT TM device. However, when iontophoresis was performed without the anion-exchange membrane, skin irritation after iontophoresis was observed at the site of use, indicating that the ion-exchange membrane plays an important role in the safety of the TCT TM device. No difference in the extent of hind paw edema was observed with and without iontophoresis (nϭ3) (Fig. 3B) . Thus, ion-exchange iontophoresis of diclofenac Ϫ had no sig- nificant anti-inflammatory effect and the plasma concentration of diclofenac Ϫ in this experiment was inadequate.
Combining Iontophoresis with Geraniol Significantly Enhanced in Vivo Transdermal Delivery and Anti-inflammatory Effect of Diclofenac As mentioned above, high efficiency transdermal delivery of diclofenac
Ϫ is required to achieve a significant anti-inflammatory effect. Since geraniol significantly increased the iontophoretic transfer of diclofenac Ϫ through the skin in vitro, we asked whether the enhancing effect of geraniol on transdermal iontophoresis occurred in vivo. As shown in Fig. 5A , the plasma concentration of diclofenac Ϫ was dramatically increased by applying geraniol on the dorsal skin just before iontophoresis. The plasma concentration of diclofenac Ϫ during iontophoresis increased in a time-dependent manner. At the end of iontophoresis, the maximal concentration reached 3 mg/ml, approximately 20-fold higher than that reached without geraniol. There were significant differences of plasma concentration of diclofenac Ϫ between with and without geraniol at the all time points measured (0.5 and 1 h: pϽ0.01, 1.5 and 2.5 h: pϽ0.05). The amounts of diclofenac Ϫ remaining in the drug solution at after iontophoresis with or without geraniol were 2.50Ϯ0.37 or 3.77Ϯ0.51 mg, respectively. Furthermore, carrageenan-induced edema in the hind paw was significantly suppressed at 0.5 h after treatment by combining iontophoretic transdermal administration of diclofenac Ϫ with geraniol (nϭ4) and tended to suppress at 1 and 1.5 h after treatment (nϭ4) (Fig. 5B) . Finally, no skin irritation after iontophoresis was observed at the site of application (Fig. 6) . The plasma concentration of diclofenac Ϫ and the carrageenan-induced edema of the hind paws of the rats were measured. Time schedule and conditions of iontophoresis were the same as Fig. 2 . Two hours after injection of carrageenan, the geraniol was applied to the dorsal skin just before the second injection of carrageenan to the other hind paw, and then iontophoresis was performed. (A) Time-course of plasma diclofenac concentration. Iontophoresis was performed for 1.5 h (from 2 to 3. Taken together, these results demonstrate that combining iontophoresis with geraniol treatment permits safe and effective in vivo delivery of diclofenac Ϫ and achieves the predicted pharmacologic outcome.
DISCUSSION
Transdermal drug delivery systems represent a novel and beneficial therapeutic approach to the delivery of pharmaceuticals such as diclofenac and other NSAIDs. However, in conventional iontophoretic systems, issues of drug availability and safety have not been resolved. In this study, a novel ion-exchange iontophoretic device was used to demonstrate transdermal delivery of diclofenac sodium as a model of anionic drugs.
When in vivo transdermal delivery of diclofenac Ϫ was examined, the plasma concentration of diclofenac Ϫ was increased up to 0.17 mg/ml by iontophoresis, but there was no significant difference among the time points measured (Fig.  3A) . Similar results were reported for in vivo iontophoretic delivery of several NSAIDs, including salicylic acid, ketoprofen, naproxen, and indomethacin. 17) Not surprisingly, antiinflammatory effects of diclofenac were not observed. The increased diclofenac Ϫ concentration in the plasma by iontophoresis seems to be too low to suppress the inflammation of hind paw.
In order to further enhance the transdermal delivery of diclofenac Ϫ , we combined ion-exchange iontophoresis with chemical enhancers such as terpenes. In previous studies of passive transfer, enhancements greater than 10-fold were induced by the same terpenes used here, but several hours of application were necessary. 18, 19) In addition, it was also shown that in vitro iontophoresis of insulin was enhanced by pre-treatment with a terpene/ethanol mixture. 14) We extended these observations by testing the combination method in vivo. We found that the plasma concentration of diclofenac Ϫ was increased 20-fold by combining iontophoresis with geraniol, and delivery was time-dependent (Fig. 5A) . Pharmacological analysis clearly demonstrated the anti-inflammatory effects of diclofenac (Fig. 5B) and toxicity was not observed (Fig. 6) .
Previously, it was suggested that the enhancing effect of terpenes on drug transfer could be attributed to increased drug diffusion and partitioning into the stratum corneum. 20) When geraniol was used with iontophoresis, the remaining diclofenac Ϫ in the drug solution was about 34% lower than that seen with iontophoresis alone. Accordingly, we suggest that the enhancing effect achieved by combining ionexchange iontophoresis with geraniol can be attributed to increased partitioning into the stratum corneum and enhanced transport across the anion-exchange membrane. The detailed mechanism by which diclofenac Ϫ transport across an anionexchange membrane is enhanced is still unclear. The effect of mixing geraniol or the other terpenes with donor drug solutions or the applicability of this combination method to other NSAIDs awaits further investigation.
The present study showed that combining ion-exchange iontophoresis with geraniol exerts a significant enhancing effect on transdermal delivery in vivo. The TCT TM device utilizing an ion-exchange membrane was not harmful to the skin. We suggest that the enhancing effect achieved by combining the ion-exchange iontophoresis with geraniol is due to improved penetration of the drug into the stratum corneum and facilitation of drug transport through the anion-exchange membrane. It is concluded that iontophoretic transdermal delivery in combination with geraniol can be a highly effective therapeutic system for diclofenac.
